Tag: ONT-380

Tag Visualization: Top 50 related tags by occurrence

Recent Related Articles to ONT-380

Array BioPharma (NASDAQ:ARRY) Receives a Higher Rating From Leerink Swann. What's The ...

Added to Collection on: 2018-01-22 21:30:00

Tags for this article:

Medicine
Clinical medicine
NASDAQ
Short
Cancer
Array BioPharma
MEK inhibitor
Tucatinib
Binimetinib
ONT-380
Larotrectinib
Selumetinib

Click the tags to see associated articles and topics

View Article Details
Are Array BioPharma (NASDAQ:ARRY) Shares a 'Buy' Now? Leerink Swann Has Upgraded The ...

Added to Collection on: 2018-01-22 21:30:00

Tags for this article:

Medicine
Clinical medicine
NASDAQ
Short
Cancer
Array BioPharma
MEK inhibitor
Tucatinib
Binimetinib
ONT-380
Larotrectinib
Selumetinib

Click the tags to see associated articles and topics

View Article Details
Will Array BioPharma Inc. (ARRY) Run Out of Steam Soon?

Added to Collection on: 2018-01-23 05:56:15

Tags for this article:

Medicine
Clinical medicine
NASDAQ
Short
Cancer
Array BioPharma
MEK inhibitor
Tucatinib
Binimetinib
ONT-380
Larotrectinib
Selumetinib

Click the tags to see associated articles and topics

View Article Details
Is Array BioPharma Inc. (ARRY) a Buy? The Stock Reaches Record High Today

Added to Collection on: 2018-01-23 05:56:15

Tags for this article:

Medicine
Clinical medicine
NASDAQ
Short
Cancer
Array BioPharma
MEK inhibitor
Tucatinib
Binimetinib
ONT-380
Larotrectinib
Selumetinib

Click the tags to see associated articles and topics

View Article Details
Array Biopharma (NASDAQ:ARRY): SunTrust Robinson Reconfirms “Buy” Rating Today, Has a ...

Added to Collection on: 2018-01-24 00:30:00

Tags for this article:

Medicine
Clinical medicine
NASDAQ
Short
Cancer
Array BioPharma
MEK inhibitor
Tucatinib
Binimetinib
ONT-380
Larotrectinib
Selumetinib

Click the tags to see associated articles and topics

View Article Details
SunTrust Robinson Has Just Reaffirmed $16.0 Target Price Per Share on Array Biopharma ...

Added to Collection on: 2018-01-24 00:30:00

Tags for this article:

Medicine
Clinical medicine
NASDAQ
Short
Cancer
Array BioPharma
MEK inhibitor
Tucatinib
Binimetinib
ONT-380
Larotrectinib
Selumetinib

Click the tags to see associated articles and topics

View Article Details
Seth Klarman's Baupost Group LlcMa Opened Huge Cascadian Therapeutics, Inc Position

Added to Collection on: 2018-02-13 09:52:30

Tags for this article:

Medicine
Clinical medicine
Americas
Baupost Group
Seth Klarman
Cascadia
Seattle Genetics
ONT-380

Click the tags to see associated articles and topics

View Article Details
Cascadian Therapeutics, Inc: Seth Klarman's Baupost Group LlcMa Disclosed Stake

Added to Collection on: 2018-02-13 09:52:30

Tags for this article:

Medicine
Clinical medicine
Economy of the United States
Baupost Group
Seth Klarman
Cascadian Therapeutics Inc.
Cascadia
Seattle Genetics
ONT-380
Oncothyreon Inc.

Click the tags to see associated articles and topics

View Article Details
Cascadian Therapeutics Target of Unusually Large Options Trading (NASDAQ:CASC)

Added to Collection on: 2018-02-18 16:37:30

Tags for this article:

Politics
Cascadian Therapeutics Inc.
Cascadia
ONT-380

Click the tags to see associated articles and topics

View Article Details
Time to Reconsider Array BioPharma Inc. (ARRY) After Achieving 52-Week High?

Added to Collection on: 2018-03-07 23:11:15

Tags for this article:

Medicine
Clinical medicine
NASDAQ
Short
Cancer
Array BioPharma
MEK inhibitor
Tucatinib
Binimetinib
ONT-380
Larotrectinib
Selumetinib

Click the tags to see associated articles and topics

View Article Details